Theriva Biologics Inc
AMEX:TOVX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Theriva Biologics Inc
AMEX:TOVX
|
US |
|
Bank Mandiri (Persero) Tbk PT
OTC:PPERF
|
ID |
|
K
|
Kerjaya Prospek Property Bhd
KLSE:KPPROP
|
MY |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Theriva Biologics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Theriva Biologics Does
Theriva Biologics is a clinical-stage biotechnology company that develops cancer treatments, mainly virus-based therapies designed to attack tumor cells and make standard drugs work better. Its lead program, VCN-01, is an engineered adenovirus meant to spread inside solid tumors and help destroy cancer from within.
- Headquarters
- United States of America US
- Employees
- 21
- IPO date
- Feb 12, 1993